NASDAQ:MKTX - MarketAxess Stock Price, News, & Analysis

MarketAxess trades on the NASDAQ under the ticker symbol "MKTX."

MarketAxess announced a quarterly dividend on Thursday, January 31st. Shareholders of record on Wednesday, February 13th will be paid a dividend of $0.51 per share on Wednesday, February 27th. This represents a $2.04 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date is Tuesday, February 12th. This is a boost from MarketAxess's previous quarterly dividend of $0.42. View MarketAxess' Dividend History.

MarketAxess declared that its board has initiated a stock buyback plan on Wednesday, October 25th 2017, which permits the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.

MarketAxess Holdings Inc. (NASDAQ:MKTX) posted its quarterly earnings results on Wednesday, January, 30th. The financial services provider reported $1.21 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.15 by $0.06. The financial services provider earned $112.44 million during the quarter, compared to analysts' expectations of $112.37 million. MarketAxess had a return on equity of 30.31% and a net margin of 39.69%. The business's revenue was up 14.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.88 earnings per share. View MarketAxess' Earnings History.

MarketAxess is scheduled to release their next quarterly earnings announcement on Wednesday, April 24th 2019. View Earnings Estimates for MarketAxess.

7 brokers have issued 12 month price objectives for MarketAxess' shares. Their forecasts range from $198.00 to $219.00. On average, they expect MarketAxess' share price to reach $209.40 in the next twelve months. This suggests that the stock has a possible downside of 12.4%. View Analyst Price Targets for MarketAxess.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MarketAxess in the last year. There are currently 1 sell rating and 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MarketAxess.

Media headlines about MKTX stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. MarketAxess earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned news coverage about the financial services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future.

Some companies that are related to MarketAxess include TD Ameritrade (AMTD), Credit Suisse Group (CS), Nomura (NMR), Raymond James (RJF), SEI Investments (SEIC), Virtu Financial (VIRT), Stifel Financial (SF), Navient (NAVI), Waddell & Reed Financial (WDR), Wisdom Tree Investments (WETF), Piper Jaffray Companies (PJC), Investment Technology Group (ITG), Associated Capital Group (AC), Gamco Investors (GBL) and Freedom (FRHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other MarketAxess investors own include AutoZone (AZO), Starbucks (SBUX), Intuitive Surgical (ISRG), NVIDIA (NVDA), Paypal (PYPL), Alphabet (GOOG), Micron Technology (MU), Netflix (NFLX), Alibaba Group (BABA) and Visa (V).

MarketAxess' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (10.69%), BlackRock Inc. (9.26%), Kayne Anderson Rudnick Investment Management LLC (4.67%), Ownership Capital B.V. (1.14%), Geode Capital Management LLC (1.09%) and Bank of New York Mellon Corp (1.08%). Company insiders that own MarketAxess stock include Antonio L Delise, David G Gomach, John Steinhardt, Kevin M Mcpherson, Nicholas Themelis, Richard M Mcvey and Stephen P Casper. View Institutional Ownership Trends for MarketAxess.

MKTX stock was sold by a variety of institutional investors in the last quarter, including Public Employees Retirement Association of Colorado, Kayne Anderson Rudnick Investment Management LLC, New York State Common Retirement Fund, Bank of America Corp DE, Victory Capital Management Inc., Rothschild & Co. Asset Management US Inc., Bank of New York Mellon Corp and California Public Employees Retirement System. Company insiders that have sold MarketAxess company stock in the last year include Antonio L Delise, David G Gomach, John Steinhardt, Kevin M Mcpherson, Nicholas Themelis and Richard M Mcvey. View Insider Buying and Selling for MarketAxess.

MKTX stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Eagle Asset Management Inc., Ownership Capital B.V., Scout Investments Inc., KAMES CAPITAL plc, Bahl & Gaynor Inc., Millennium Management LLC and Rhumbline Advisers. View Insider Buying and Selling for MarketAxess.

Shares of MKTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MKTX stock can currently be purchased for approximately $238.97.

MarketAxess has a market capitalization of $8.98 billion and generates $435.57 million in revenue each year. The financial services provider earns $172.85 million in net income (profit) each year or $4.57 on an earnings per share basis. MarketAxess employs 429 workers across the globe.

The official website for MarketAxess is http://www.marketaxess.com.

MarketAxess' mailing address is 299 PARK AVENUE 10TH FLOOR, NEW YORK NY, 10171. The financial services provider can be reached via phone at 212-813-6000 or via email at [email protected]